Human leukocyte antigens influence the immune response to a pre-S/S hepatitis B vaccine

By McDermott A.B.   Cohen S.B.A.   Zuckerman J.N.   Madrigal J.A.  

Vaccine, Vol. 17, Iss. 4, 1999-02 ,pp. : 330-339

Elsevier

Access to resources Recommend Favorite

Immune response to an indigenously developed hepatitis-B (Shanvac-B) vaccine in a tribal community of India

By Murhekar M.V.   Murhekar K.M.   Arankalle V.A.   Sehgal S.C.  

Vaccine, Vol. 20, Iss. 29, 2002-10 ,pp. : 3431-3435

Elsevier

Access to resources Recommend Favorite

Immune response of HLA DQ2 positive subjects, vaccinated with HBsAg/AS04, a hepatitis B vaccine with a novel adjuvant

By Desombere I.   Van der Wielen M.   Van Damme P.   Stoffel M.   De Clercq N.   Goilav C.   Leroux-Roels G.  

Vaccine, Vol. 20, Iss. 19, 2002-06 ,pp. : 2597-2602

Elsevier

Access to resources Recommend Favorite

Enhanced type I immune response to a hepatitis B DNA vaccine by formulation with calcium- or aluminum phosphate

By Wang S.   Liu X.   Fisher K.   Smith J.G.   Chen F.   Tobery T.W.   Ulmer J.B.   Evans R.K.   Caulfield M.J.  

Vaccine, Vol. 18, Iss. 13, 2000-01 ,pp. : 1227-1235

Elsevier

Access to resources Recommend Favorite

Immune response and vaccine efficiency

By Schlegel M.   Vernazza P.L.  

Vaccine, Vol. 16, Iss. 13, 1998-08 ,pp. : 1256-1256

Elsevier

Access to resources Recommend Favorite